{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:14:04Z","timestamp":1791180844786,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"33","license":[{"start":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T00:00:00Z","timestamp":1416787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T00:00:00Z","timestamp":1416787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,8,13]]},"DOI":"10.1038\/onc.2014.363","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T10:59:03Z","timestamp":1416826743000},"page":"4333-4346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function"],"prefix":"10.1038","volume":"34","author":[{"given":"E","family":"Kumaraswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K L","family":"Wendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L A","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R","family":"Stecklein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E C","family":"Sibala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gunewardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,24]]},"reference":[{"key":"BFonc2014363_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.7939630","volume":"266","author":"PA Futreal","year":"1994","unstructured":"Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120\u2013122.","journal-title":"Science"},{"key":"BFonc2014363_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10911-011-9213-5","volume":"16","author":"AY Shuen","year":"2011","unstructured":"Shuen AY, Foulkes WD . Inherited mutations in breast cancer genes\u2014risk and response. J Mammary Gland Biol Neoplasia 2011; 16: 3\u201315.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"BFonc2014363_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747\u2013752.","journal-title":"Nature"},{"key":"BFonc2014363_CR4","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/jnci\/djg050","volume":"95","author":"WD Foulkes","year":"2003","unstructured":"Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003; 95: 1482\u20131485.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2014363_CR5","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s12015-012-9354-y","volume":"8","author":"NE Buckley","year":"2012","unstructured":"Buckley NE, Mullan PB . BRCA1 - conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer. Stem Cell Rev 2012; 8: 982\u2013993.","journal-title":"Stem Cell Rev"},{"key":"BFonc2014363_CR6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm.2000","volume":"15","author":"E Lim","year":"2009","unstructured":"Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nature Med 2009; 15: 907\u2013913.","journal-title":"Nature Med"},{"key":"BFonc2014363_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.stem.2010.07.010","volume":"7","author":"G Molyneux","year":"2010","unstructured":"Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010; 7: 403\u2013417.","journal-title":"Cell Stem Cell"},{"key":"BFonc2014363_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng0495-444","volume":"9","author":"ME Thompson","year":"1995","unstructured":"Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT . Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995; 9: 444\u2013450.","journal-title":"Nat Genet"},{"key":"BFonc2014363_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/ng0396-298","volume":"12","author":"JT Holt","year":"1996","unstructured":"Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC et al. Growth retardation and tumour inhibition by BRCA1. Nat Genet 1996; 12: 298\u2013302.","journal-title":"Nat Genet"},{"key":"BFonc2014363_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nrc1457","volume":"4","author":"N Turner","year":"2004","unstructured":"Turner N, Tutt A, Ashworth A . Hallmarks of 'BRCAness' in sporadic cancers. Nat Rev Cancer 2004; 4: 814\u2013819.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014363_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","volume":"103","author":"J Schlessinger","year":"2000","unstructured":"Schlessinger J . Cell signaling by receptor tyrosine kinases. Cell 2000; 103: 211\u2013225.","journal-title":"Cell"},{"key":"BFonc2014363_CR12","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0959-8049(01)00230-1","volume":"37","author":"Y Yarden","year":"2001","unstructured":"Yarden Y . The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer 2001; 37: S3\u2013S8.","journal-title":"Eur J Cancer"},{"key":"BFonc2014363_CR13","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24816","volume":"116","author":"MF Rimawi","year":"2010","unstructured":"Rimawi MF, Shetty PB, Weiss HL, Schiff R, Osborne CK, Chamness GC et al. Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes. Cancer 2010; 116: 1234\u20131242.","journal-title":"Cancer"},{"key":"BFonc2014363_CR14","first-page":"1398","volume":"1","author":"JR Sainsbury","year":"1987","unstructured":"Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL . Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1987; 1: 1398\u20131402.","journal-title":"Lancet"},{"key":"BFonc2014363_CR15","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","volume":"37","author":"RI Nicholson","year":"2001","unstructured":"Nicholson RI, Gee JM, Harper ME . EGFR and cancer prognosis. Eur J Cancer 2001; 37: S9\u201315.","journal-title":"Eur J Cancer"},{"key":"BFonc2014363_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10549-008-0206-z","volume":"116","author":"G Viale","year":"2009","unstructured":"Viale G, Rotmensz N, Maisonneuve P, Bottiglieri L, Montagna E, Luini A et al. Invasive ductal carcinoma of the breast with the \"triple-negative\" phenotype: prognostic implications of EGFR immunoreactivity. Breast Cancer Res Treat 2009; 116: 317\u2013328.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2014363_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/jcp.2008.056291","volume":"62","author":"JB Arnes","year":"2009","unstructured":"Arnes JB, Begin LR, Stefansson I, Brunet JS, Nielsen TO, Foulkes WD et al. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer. J Clin Pathol 2009; 62: 139\u2013146.","journal-title":"J Clin Pathol"},{"key":"BFonc2014363_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/1471-2407-8-309","volume":"8","author":"T Toyama","year":"2008","unstructured":"Toyama T, Yamashita H, Kondo N, Okuda K, Takahashi S, Sasaki H et al. Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers. BMC Cancer 2008; 8: 309.","journal-title":"BMC Cancer"},{"key":"BFonc2014363_CR19","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1128\/MCB.00961-07","volume":"27","author":"E Kumaraswamy","year":"2007","unstructured":"Kumaraswamy E, Shiekhattar R . Activation of BRCA1\/BRCA2-associated helicase BACH1 is required for timely progression through S phase. Molecular Cell Biol 2007; 27: 6733\u20136741.","journal-title":"Molecular Cell Biol"},{"key":"BFonc2014363_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nrm2831","volume":"11","author":"MS Huen","year":"2010","unstructured":"Huen MS, Sy SM, Chen J . BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 2010; 11: 138\u2013148.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2014363_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1158\/2159-8290.CD-12-0221","volume":"2","author":"DP Silver","year":"2012","unstructured":"Silver DP, Livingston DM . Mechanisms of BRCA1 tumor suppression. Cancer Discov 2012; 2: 679\u2013684.","journal-title":"Cancer Discov"},{"key":"BFonc2014363_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s10549-009-0565-0","volume":"122","author":"JJ Gorski","year":"2010","unstructured":"Gorski JJ, James CR, Quinn JE, Stewart GE, Staunton KC, Buckley NE et al. BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer. Breast Cancer Res Treat 2010; 122: 721\u2013731.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2014363_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215\u2013233.","journal-title":"Cell"},{"key":"BFonc2014363_CR24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nature03868","volume":"436","author":"TP Chendrimada","year":"2005","unstructured":"Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436: 740\u2013744.","journal-title":"Nature"},{"key":"BFonc2014363_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/emmm.201100209","volume":"4","author":"MV Iorio","year":"2012","unstructured":"Iorio MV, Croce CM . MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012; 4: 143\u2013159.","journal-title":"EMBO Mol Med"},{"key":"BFonc2014363_CR26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1158\/0008-5472.CAN-08-3559","volume":"69","author":"DR Hurst","year":"2009","unstructured":"Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR . Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 2009; 69: 1279\u20131283.","journal-title":"Cancer Res"},{"key":"BFonc2014363_CR27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/msb.2011.100","volume":"8","author":"S Uhlmann","year":"2012","unstructured":"Uhlmann S, Mannsperger H, Zhang JD, Horvat EA, Schmidt C, Kublbeck M et al. Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer. Mol Syst Biol 2012; 8: 570.","journal-title":"Mol Syst Biol"},{"key":"BFonc2014363_CR28","first-page":"120","volume":"1766","author":"S Sebastian","year":"2006","unstructured":"Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A, Paradiso A . The complexity of targeting EGFR signalling in cancer: from expression to turnover. Biochim Biophys Acta 2006; 1766: 120\u2013139.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2014363_CR29","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD, Boldin MP, Chang KJ, Baltimore D . NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481\u201312486.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014363_CR30","doi-asserted-by":"publisher","first-page":"D91","DOI":"10.1093\/nar\/gkh012","volume":"32","author":"A Sandelin","year":"2004","unstructured":"Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B . JASPAR: an open-access database for eukaryotic transcription factor binding profiles. . Nucleic Acids Res 2004; 32: D91\u2013D94.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2014363_CR31","first-page":"4222","volume":"62","author":"N Chiba","year":"2002","unstructured":"Chiba N, Parvin JD . The BRCA1 and BARD1 association with the RNA polymerase II holoenzyme. Cancer Res 2002; 62: 4222\u20134228.","journal-title":"Cancer Res"},{"key":"BFonc2014363_CR32","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/pros.22466","volume":"72","author":"B Xu","year":"2011","unstructured":"Xu B, Wang N, Wang X, Tong N, Shao N, Tao J et al. MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer. Prostate 2011; 72: 1171\u20131178.","journal-title":"Prostate"},{"key":"BFonc2014363_CR33","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-09-2792","volume":"70","author":"Y Li","year":"2010","unstructured":"Li Y, Vandenboom TG 2nd, Wang Z, Kong D, Ali S, Philip PA et al. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res 2010; 70: 1486\u20131495.","journal-title":"Cancer Res"},{"key":"BFonc2014363_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.yexcr.2009.11.006","volume":"316","author":"BW Booth","year":"2010","unstructured":"Booth BW, Boulanger CA, Anderson LH, Jimenez-Rojo L, Brisken C, Smith GH . Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics. Exp Cell Res 2010; 316: 422\u2013432.","journal-title":"Exp Cell Res"},{"key":"BFonc2014363_CR35","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1101\/gad.1061803","volume":"17","author":"G Dontu","year":"2003","unstructured":"Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ et al. In vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells. Genes Dev 2003; 17: 1253\u20131270.","journal-title":"Genes Dev"},{"key":"BFonc2014363_CR36","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/bcr2850","volume":"13","author":"LN Burga","year":"2011","unstructured":"Burga LN, Hu H, Juvekar A, Tung NM, Troyan SL, Hofstatter EW et al. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. Breast Cancer Res 2011; 13: R30.","journal-title":"Breast Cancer Res"},{"key":"BFonc2014363_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-011-1905-4","volume":"134","author":"M Tanic","year":"2011","unstructured":"Tanic M, Zajac M, Gomez-Lopez G, Benitez J, Martinez-Delgado B . Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFkappaB pathway. Breast Cancer Res Treat 2011; 134: 41\u201351.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2014363_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/emmm.201100136","volume":"3","author":"AI Garcia","year":"2011","unstructured":"Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E, Lopez BS et al. Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med 2011; 3: 279\u2013290.","journal-title":"EMBO Mol Med"},{"key":"BFonc2014363_CR39","doi-asserted-by":"publisher","first-page":"e31615","DOI":"10.1371\/journal.pone.0031615","volume":"7","author":"H Lian","year":"2012","unstructured":"Lian H, Wang L, Zhang J . Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans. PLoS ONE 2012; 7: e31615.","journal-title":"PLoS ONE"},{"key":"BFonc2014363_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1083\/jcb.201110008","volume":"197","author":"S Kawai","year":"2012","unstructured":"Kawai S, Amano A . BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex. J Cell Biol 2012; 197: 201\u2013208.","journal-title":"J Cell Biol"},{"key":"BFonc2014363_CR41","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.1073\/pnas.94.11.5605","volume":"94","author":"R Scully","year":"1997","unstructured":"Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA et al. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci USA 1997; 94: 5605\u20135610.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014363_CR42","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/nm.2459","volume":"17","author":"S Chang","year":"2011","unstructured":"Chang S, Wang RH, Akagi K, Kim KA, Martin BK, Cavallone L et al. Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med 2011; 17: 1275\u20131282.","journal-title":"Nat Med"},{"key":"BFonc2014363_CR43","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10059-012-0118-y","volume":"34","author":"S Chang","year":"2012","unstructured":"Chang S, Sharan SK . BRCA1 and MicroRNAs: emerging networks and potential therapeutic targets. Mol Cells 2012; 34: 425\u2013432.","journal-title":"Mol Cells"},{"key":"BFonc2014363_CR44","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1128\/MCB.05821-11","volume":"31","author":"J Mei","year":"2011","unstructured":"Mei J, Bachoo R, Zhang CL . MicroRNA-146a inhibits glioma development by targeting Notch1. Mol Cell Biol 2011; 31: 3584\u20133592.","journal-title":"Mol Cell Biol"},{"key":"BFonc2014363_CR45","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1038\/onc.2008.171","volume":"27","author":"D Bhaumik","year":"2008","unstructured":"Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC . Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 2008; 27: 5643\u20135647.","journal-title":"Oncogene"},{"key":"BFonc2014363_CR46","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1084\/jem.20101823","volume":"208","author":"MP Boldin","year":"2011","unstructured":"Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011; 208: 1189\u20131201.","journal-title":"J Exp Med"},{"key":"BFonc2014363_CR47","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1073\/pnas.1105398108","volume":"108","author":"JL Zhao","year":"2011","unstructured":"Zhao JL, Rao DS, Boldin MP, Taganov KD, O'Connell RM, Baltimore D . NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci USA 2011; 108: 9184\u20139189.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014363_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ceb.2008.12.010","volume":"21","author":"NE Hynes","year":"2009","unstructured":"Hynes NE, MacDonald G . ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol 2009; 21: 177\u2013184.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc2014363_CR49","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1471-2164-8-258","volume":"8","author":"KA Hoadley","year":"2007","unstructured":"Hoadley KA, Weigman VJ, Fan C, Sawyer LR, He X, Troester MA et al. EGFR associated expression profiles vary with breast tumor subtype. BMC Genomics 2007; 8: 258.","journal-title":"BMC Genomics"},{"key":"BFonc2014363_CR50","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/jnci\/djk133","volume":"99","author":"G Farnie","year":"2007","unstructured":"Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, Anderson NG et al. Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst 2007; 99: 616\u2013627.","journal-title":"J Natl Cancer Inst"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2014363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014363","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:38:05Z","timestamp":1647895085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2014363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,24]]},"references-count":50,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2015,8,13]]}},"alternative-id":["BFonc2014363"],"URL":"https:\/\/doi.org\/10.1038\/onc.2014.363","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,24]]},"assertion":[{"value":"26 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}